急性冠状动脉综合征住院患者药学监护的实施效果评价
|
摘要
目的评价急性冠状动脉综合征(ACS)住院患者药学监护(PC)的实施效果。方法选取202例ACS患者,分析患者的基本详细信息,评估药物治疗中存在的问题,针对在治疗中存在的问题,给予相应的干预措施。统计随访结果。结果 202例患者基本遵循ACS的治疗指南,发现存在有效性以及安全性问题。针对在治疗中存在的问题,给予相应的干预措施,包括加强与医师及护士之间的沟通交流;对患者进行科学专业的用药教育;与护士进行药物知识的交流,提高护士药学专业知识。干预3个月后, 202例患者血压达标率为56.9%(115/202);静息心率达标率为76.2%(154/202);空腹血葡萄糖达标率为66.3%(134/202);糖化血红蛋白达标率为70.3%(142/202)。结论对ACS实施药物监护能够有效促进药物的合理使用,提高药物治疗的安全、有效性,值得推广应用。
Objective To evaluate the implementation effect of pharmaceutical care(PC) in hospitalized patients with acute coronary syndrome(ACS). Methods The basic details of 202 patients with ACS were analyzed, and the problems in drug treatment were evaluated. In view of the existing problems in the treatment, the corresponding intervention measures was performed. The follow-up results was collected. Results 202 patients basically followed ACS treatment guidelines, but there were effectiveness and safety problems. In view of the existing problems in the treatment, the corresponding intervention measures should be performed, including strengthening communication with doctors and nurses, carrying out scientific and professional drug education for patients, and communicating drug knowledge with nurses to improve nurses' professional knowledge of pharmacy. After 3 months of intervention, 202 patients had compliance rates of blood pressure, resting heart rate, fasting blood glucose and glycosylated hemoglobin as 56.9%(115/202), 76.2%(154/202), 66.3%(134/202) and 70.3%(142/202) respectively. Conclusion Pharmaceutical care for ACS can effectively promote the rational use of drugs and improve the safety and effectiveness of drug treatment, and it is worthy of promotion and application.
Objective To evaluate the implementation effect of pharmaceutical care(PC) in hospitalized patients with acute coronary syndrome(ACS). Methods The basic details of 202 patients with ACS were analyzed, and the problems in drug treatment were evaluated. In view of the existing problems in the treatment, the corresponding intervention measures was performed. The follow-up results was collected. Results 202 patients basically followed ACS treatment guidelines, but there were effectiveness and safety problems. In view of the existing problems in the treatment, the corresponding intervention measures should be performed, including strengthening communication with doctors and nurses, carrying out scientific and professional drug education for patients, and communicating drug knowledge with nurses to improve nurses' professional knowledge of pharmacy. After 3 months of intervention, 202 patients had compliance rates of blood pressure, resting heart rate, fasting blood glucose and glycosylated hemoglobin as 56.9%(115/202), 76.2%(154/202), 66.3%(134/202) and 70.3%(142/202) respectively. Conclusion Pharmaceutical care for ACS can effectively promote the rational use of drugs and improve the safety and effectiveness of drug treatment, and it is worthy of promotion and application.
引文
[1]Jia H, Abtahian F, Aguirre AD, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. Journal of American College of Cardiology, 2013, 62(19):1748-1758.
[2]季闽春,钱庆庆,沈晓英,等.急性冠状动脉综合征住院患者药学监护的实施效果评价.中国临床药学杂志, 2016, 25(4):240-244.
[3]杨昭毅,向倩,周颖,等.急性冠状动脉综合征介入治疗应用替罗非班致极重度血小板减少症.中国临床药理学杂志, 2015,31(16):1665-1667.
[4]卜一珊,徐彦贵,陈凡,等.分级药学监护制定与实施的探讨.中国医院药学杂志, 2015, 35(24):2163-2165.
[5]赵成龙,张闽闽,陈杨,等. 2例阿帕替尼致不良反应的药学监护.中国新药杂志, 2016, 25(2):238-240, 197.
[6]向竹枝,吴方建. 1例急性冠状动脉综合征患者PCI围手术期抗栓治疗的药学监护.医药导报, 2016, 35(8):893-895.
[7]冯侠侠.急性冠状动脉综合征出血评分系统在药学服务中的应用.药学服务与研究, 2013, 13(2):98-102.
[2]季闽春,钱庆庆,沈晓英,等.急性冠状动脉综合征住院患者药学监护的实施效果评价.中国临床药学杂志, 2016, 25(4):240-244.
[3]杨昭毅,向倩,周颖,等.急性冠状动脉综合征介入治疗应用替罗非班致极重度血小板减少症.中国临床药理学杂志, 2015,31(16):1665-1667.
[4]卜一珊,徐彦贵,陈凡,等.分级药学监护制定与实施的探讨.中国医院药学杂志, 2015, 35(24):2163-2165.
[5]赵成龙,张闽闽,陈杨,等. 2例阿帕替尼致不良反应的药学监护.中国新药杂志, 2016, 25(2):238-240, 197.
[6]向竹枝,吴方建. 1例急性冠状动脉综合征患者PCI围手术期抗栓治疗的药学监护.医药导报, 2016, 35(8):893-895.
[7]冯侠侠.急性冠状动脉综合征出血评分系统在药学服务中的应用.药学服务与研究, 2013, 13(2):98-102.